Abstract
Ghrelin, leptin, and adiponectin play an important role in the regulation of energetic
homeostasis, but physiological relationships between these hormones have not been
elucidated. This study was therefore designed to characterize the association between
serum acylated ghrelin, leptin, and adiponectin levels, as well as insulin resistance
evaluated by homeostasis model of assessment in 32 normal-weight and 60 age-matched
metabolically healthy obese women. In normal-weight, but not in obese women, we found
a positive linear correlation between leptin and ghrelin (r=0.375; p=0.034). In the
multiply regression analysis we observed the change of direction of leptin influence
on acylated ghrelin level from positive in normal-weight (p=0.001) to negative in
obese women without insulin-resistance (p=0.033); in obese women with insulin resistance
leptin was not significantly associated with ghrelin. In neither group was any linear
correlation found between ghrelin and adiponectin. However, by multivariate analysis
adiponectin was positively associated with ghrelin, but only in obese women without
insulin resistance (p=0.01). In conclusion, in normal-weight women leptin is positively
correlated with acylated ghrelin. In obese women without insulin resistance different
interactions between both hormones might reflect a physiological mechanism of adaptation
to a positive energy balance.
Key words
insulin sensitivity - adipokines - obesity
References
- 1
Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L,
Lehy T, Guerre-Millo M, Marchand-Brustel Y, Lewin MJ.
The stomach is a source of leptin.
Nature.
1998;
394
790-793
- 2
Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K,
Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K,
Nakao K.
Stomach is a major source of circulating ghrelin, and feeding state determines plasma
ghrelin-like immunoreactivity levels in humans.
J Clin Endocrinol Metab.
2001;
86
4753-4758
- 3
Broberger C.
Brain regulation of food intake and appetite: molecules and networks.
J Intern Med.
2005;
258
301-327
- 4
Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S.
Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia,
and leptin administration.
Biochem Biophys Res Commun.
2001;
281
1220-1225
- 5
Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A,
Fujino MA, Kasuga M.
Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance
to motilin.
Gastroenterology.
2001;
120
337-345
- 6
Barazzoni R, Zanetti M, Stebel M, Biolo G, Cattin L, Guarnieri G.
Hyperleptinemia prevents increased plasma ghrelin concentration during short-term
moderate caloric restriction in rats.
Gastroenterology.
2003;
124
1188-1192
- 7
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in
humans.
Diabetes.
2001;
50
1714-1719
- 8
Caixas A, Bashore C, Nash W, Pi-Sunyer F, Laferrere B.
Insulin, unlike food intake, does not suppress ghrelin in human subjects.
J Clin Endocrinol Metab.
2002;
87
1902
- 9
Chan JL, Bullen J, Lee JH, Yiannakouris N, Mantzoros CS.
Ghrelin levels are not regulated by recombinant leptin administration and/or three
days of fasting in healthy subjects.
J Clin Endocrinol Metab.
2004;
89
335-343
- 10
Chanoine JP, Yeung LP, Wong AC, Birmingham CL.
Immunoreactive ghrelin in human cord blood: relation to anthropometry, leptin, and
growth hormone.
J Pediatr Gastroenterol Nutr.
2002;
35
282-286
- 11
Rosicka M, Krsek M, Matoulek M, Jarkovska Z, Marek J, Justova V, Lacinova Z.
Serum ghrelin levels in obese patients: the relationship to serum leptin levels and
soluble leptin receptors levels.
Physiol Res.
2003;
52
61-66
- 12
Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML.
Circulating ghrelin levels are decreased in human obesity.
Diabetes.
2001;
50
707-709
- 13
Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K,
Sugihara S.
Fasting plasma ghrelin levels are negatively correlated with insulin resistance and
PAI-1, but not with leptin, in obese children and adolescents.
Diabetes.
2002;
51
3408-3411
- 14
Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ.
Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food
intake.
Science.
2005;
310
996-999
- 15
Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M.
Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin.
Gut.
2005;
54
18-24
- 16
Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K.
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1
(AdiPose Most abundant Gene transcript 1).
Biochem Biophys Res Commun.
1996;
221
286-289
- 17
Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF,
Havel PJ, Pratley RE, Bogardus C, Tataranni PA.
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor
tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body
insulin sensitivity in humans.
Diabetes.
2002;
51
1884-1888
- 18
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S,
Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R,
Kahn B, Kadowaki T.
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating
AMP-activated protein kinase.
Nat Med.
2002;
8
1288-1295
- 19
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man.
Diabetologia.
1985;
28
412-419
- 20
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III) .
Final report.
Circulation.
2002;
106
3143-3421
- 21
Taniguchi A, Fukushima M, Sakai M, Kataoka K, Miwa K, Nagata I, Doi K, Tokuyama K,
Nakai Y.
Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic
patients.
Diabetes Care.
1999;
22
2100-2101
- 22
Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, Di Blasio A,
Liuzzi A.
The relationship between active ghrelin levels and human obesity involves alterations
in resting energy expenditure.
J Clin Endocrinol Metab.
2004;
89
936-939
- 23
Bagnasco M, Dube MG, Katz A, Kalra PS, Kalra SP.
Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia
but stimulates ghrelin.
Obes Res.
2003;
11
1463-1470
- 24
Beretta E, Dube MG, Kalra PS, Kalra SP.
Long-term suppression of weight gain, adiposity, and serum insulin by central leptin
gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating
genes.
Pediatr Res.
2002;
52
189-198
- 25
St-Pierre DH, Karelis AD, Coderre L, Malita F, Fontaine J, Mignault D, Brochu M, Bastard J-P,
Cianflone K, Doucet E, Imbeault P, Rabasa-Lhoret R.
Association of acylated and non-acylated ghrelin with insulin sensitivity in overweight
and obese postmenopausal women.
J Clin Endocrinol Metab.
2007;
92
264-269
- 26
Patterson M, Murphy KG, Roux CW le, Ghatei MA, Bloom SR.
Characterization of ghrelin-like immunoreactivity in human plasma.
J Clin Endocrinol Metab.
2005;
90
2205-2211
- 27
Popovic V, Duntas LH.
Leptin TRH and ghrelin: influence on energy homeostasis at rest and during exercise.
Horm Metab Res.
2005;
37
533-537
- 28
Gauna C, Delhanty PJ, Hofland LJ, Janssen JA, Broglio F, Ross RJ, Ghigo E, Lely AJ
van der.
Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary
hepatocytes.
J Clin Endocrinol Metab.
2005;
90
1055-1060
- 29
Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ.
Acute stimulation of glucose metabolism in mice by leptin treatment.
Nature.
1997;
389
374-377
- 30
Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.
The associations between plasma adiponectin, ghrelin levels and cardiovascular risk
factors.
Eur J Endocrinol.
2004;
150
715-718
- 31
Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA.
Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in
obese humans.
J Clin Endocrinol Metab.
2003;
88
3177-3183
- 32
Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A.
Beta cell function, insulin resistance and plasma adiponectin are predictors for the
change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.
Horm Metab Res.
2006;
38
178-182
Correspondence
T. Miazgowski
Department of Endocrinology
Metabolic Diseases and Internal Diseases
Pomeranian Medical University
Ul. Arkonńska 4
71455 Szczecin
Poland
Phone: +48/60/239 87 23
Fax: +48/91/454 20 42
Email: miazgowski@interia.pl